Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$34.45 - $53.48 $1.19 Million - $1.85 Million
-34,631 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$31.52 - $53.81 $1.09 Million - $1.86 Million
34,631 New
34,631 $1.23 Million
Q4 2018

Feb 13, 2019

SELL
$42.73 - $76.53 $237,877 - $426,042
-5,567 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$71.67 - $91.95 $398,986 - $511,885
5,567 New
5,567 $429,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.